Sorry, no results were found, search again?
25 Mar 2019
Oncostellae participates at the BIO-Europe partnering conference in Vienna
10 Dec 2018
GI-restricted Jak3/Tyk2 inhibitor OST-122 well tolerated in clinical phase Ia study
23 Jul 2018
Oncostellae initiated clinical development of OST-122